ClinicalTrials.gg
RecruitingNCT06814574Updated Feb 7, 2025

Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement

An observational study in AV Block Complete and Tricuspid Regurgitation (TR), sponsored by Deutsches Herzzentrum Muenchen. Recruiting at 1 site in Germany. Per ClinicalTrials.gov, last updated 2025-02-07.

Sponsored by Deutsches Herzzentrum Muenchen · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
25
Sex
All
01

Study summary

Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.

02

Conditions studied

  • AV Block Complete
  • Tricuspid Regurgitation (TR)
03

In context

Tricuspid Valve Insufficiency

226 studies on the registry are indexed under Tricuspid Valve Insufficiency; 109 are open to participants now.

This study's planned enrollment of 25 is below the median of 200 across 94 observational studies indexed under Tricuspid Valve Insufficiency.

Browse Tricuspid Valve Insufficiency studies →

Lead sponsor

Deutsches Herzzentrum Muenchen is the lead sponsor of 114 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will include every patient with a transcatheter tricuspid valve replacement in the study period.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Transcatheter Tricuspid Valve Replacement

Exclusion criteria

Exclusion Criteria:

  • no defined exclusion criteria
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
25 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Success

    The number of patients in whom the initially chosen pacemaker implantation approach was successfully performed, relative to all pacemaker implantations following TTVI.

    Time frame: at the time of surgery

  2. Feasibility

    Successful pacemaker implantation, regardless of the type of pacemaker, in relation to all patients with a relevant indication following TTVR.

    Time frame: at the time of surgery

  3. Safety

    Peri- and postprocedural complications associated with pacemaker implantation after TTVR.

    Time frame: through study completion (an average of 6 Months)

Secondary outcomes

  1. Type of Pacemaker Implantation

    eg. Leadless, right ventricular lead, coronary sinus lead, epicardial lead

    Time frame: at the time of surgery

  2. Pacemaker Implantation - Procedural Details

    Procedural Details of the pacemaker Implantation, e.g. Fluoroscopy Time, OP-Duration.

    Time frame: at the time of surgery

  3. Electric Performance

    Performance of the electrical pacemaker parameters (e.g. Sensing, Stimulation Threshold, Impedance). Intraoperative measurements and routine device-interrogations in follow-Up.

    Time frame: at the time of surgery, through study completion (an average of 6 Months)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06814574
Responsible party
Sponsor
First posted
Feb 7, 2025
Start date
Jan 1, 2024
Primary completion
Jan 31, 2025 (estimated)
Completion
Jan 31, 2025 (estimated)
Last update
Feb 7, 2025

Study contacts

Carsten Lennerz, PD Dr. med.
Contact
lennerz@dhm.mhn.de
0049 89 1218 4401

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion